Today, Augmedix announced that it has received $19 million in Series B funding that includes investments from Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments and others.
McKesson and Augmedix Expand Collaboration to Enhance the Doctor-Patient Relationship
McKesson Corporation, which has been investing in technologies and services that create greater efficiencies for healthcare providers, announced an expansion to its collaboration with Augmedix.
Augmedix, powered by Glass, accelerates scaling efforts with the nation’s leading healthcare systems
Augmedix Support Clinicians on the Front Lines – New Augmedix Capabilities Elevate Support to Doctors Treating COVID-19
